PCS-12852
- Generic Name
- PCS-12852
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
- First Posted Date
- 2022-03-08
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Processa Pharmaceuticals
- Target Recruit Count
- 25
- Registration Number
- NCT05270460
- Locations
- 🇺🇸
Long Island Gastrointestinal Research Group, Great Neck, New York, United States
🇺🇸APF Research, LLC, Miami, Florida, United States
🇺🇸Torrance Clinical Research Institute, Inc., Lomita, California, United States
Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852
- First Posted Date
- 2017-12-22
- Last Posted Date
- 2017-12-22
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03381703
- Locations
- 🇰🇷
Seoul National University Hospital Clinical Trial Center, Seoul, Korea, Republic of
Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects
- First Posted Date
- 2013-06-06
- Last Posted Date
- 2015-05-08
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 127
- Registration Number
- NCT01870674
- Locations
- 🇰🇷
Inje Busan Paik hospital, Busan, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath